FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称ISCALIMAB
异名/同义词CFZ533
CFZ-533
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD40 ANTIGEN),(HUMAN MONOCLONAL CLONE NVS240705 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CLONE NVS240705 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 5 (B-CELL SURFACE ANTIGEN CD40))HUMAN MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-450) (HOMO SAPIENS VH (IGHV3-30*03 (94%) (IGHD)-IGHJ4*01) (8.8.13) (1-120)-HOMO SAPIENS IGHG1*03 (CH2(N67>A(300))) (121-450)) (223-219')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-219') (HOMO SAPIENS V-KAPPA (IGKV2-28*01 (95%) IGKJ3*01 (92%))(11.3.9) (1'-112')-HOMO SAPIENS IGKC*01 (113'-219')), DIMER (229-229'':232-232'')-BISDISULFIDE
ISCALIMAB
ISCALIMAB [INN]
ISCALIMAB [USAN]
ISCALIMAB [WHO-DD]
NVP-CFZ533
CAS登记号2031153-61-2
物质唯一标识(Unique Ingredient Identifier)0628T707D0
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System